Mcneil Cons Drug Patent Portfolio
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|
Mcneil Cons's Family Patents
Clinical Trials
Recent Clinical Trials by Mcneil Cons:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | NA |
COMPLETED
(Apr, 2010)
| PHASE2 |
Mcneil Cons Drug List
Given below is the complete list of Mcneil Cons's drugs and the patents protecting them.
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List